Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$8.24 -0.62 (-7.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Preferred Shares (2015 - 2017)

Corbus Pharmaceuticals Holdings (CRBP) posted Preferred Shares of $10.0 million for Q4 2017, little changed on a QoQ basis from $10.0 million in Q4 2016, and little changed year-over-year from $10.0 million in Q4 2016.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Preferred Shares (2015 - 2017) Analysis & Trends

Corbus Pharmaceuticals Holdings has reported Preferred Shares for 3 years, with the latest figure at $10.0 million in Q4 2017.

  • On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $10.0 million in Q4 2017; TTM through Dec 2017 was $10.0 million, a 0.0% change from a year earlier, with the FY2017 full-year figure at $10.0 million, changed 0.0% from the prior year.
  • Preferred Shares was $10.0 million for Q4 2017 at Corbus Pharmaceuticals Holdings, roughly flat from $10.0 million in the prior quarter.
  • The five-year high for Preferred Shares was $10.0 million in Q4 2015, with the low at $10.0 million in Q4 2015.
  • Average Preferred Shares over 3 years is $10.0 million, with a median of $10.0 million recorded in 2015.
  • The largest YoY upside for Preferred Shares was 0.0% in 2016 against a maximum downside of 0.0% in 2016.
  • Over 3 years, Preferred Shares stood at $10.0 million in 2015, then changed by 0.0% to $10.0 million in 2016, then changed by 0.0% to $10.0 million in 2017.
  • The last three Preferred Shares figures came in at $10.0 million (Q4 2017), $10.0 million (Q4 2016), and $10.0 million (Q4 2015), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Corbus Pharmaceuticals Holdings 101.29 Mn -61.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 10.00 Mn
Dec 31, 2016 10.00 Mn
Dec 31, 2015 10.00 Mn